How to Get Drugs Into the Brain
Drug Hunter
AUGUST 21, 2023
Recent promising results from a Phase 2/3 trial support the use of a single oral dose of brain-penetrant acoziborole (SCYX-7158) for HAT treatment. A) Progression of a Novartis HAT program from a screening hit to brain-penetrant leads. 2016 , 7 (6), 767-775. Figure 18. link] (Pfizer) Wager, T.T.; Verhoest, P.R.;
206 
Let's personalize your content